ArticleInternational journal of molecular sciences2019

TUBB3 Reverses Resistance to Docetaxel and Cabazitaxel in Prostate Cancer.

Yohei Sekino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.